In a recent decision the new Swiss Federal Patent Court confirmed that it adheres to the case law with regard of the wording of prayers for relief in Swiss patent proceedings. Unlike in other jurisdictions, plaintiffs in Swiss patent proceedings must be very careful if they just adopt the wording from their patent claims in…

In a decision dated 14 June 2012, the Swiss Federal Patent Court granted a patent holder’s request for preliminary taking of evidence by means of the creation of a precise description of an allegedly infringing process. The Patent Court ordered that the description shall be carried out at defendant’s premises by a technically trained judge…

The numerus clausus of legally permissible pieces of evidence in the new Swiss Civil Procedure Code (CPC) – unlike in many other codes of civil procedure – does not provide for private expert opinions. Only court-appointed expert opinions are foreseen in the CPC. The question therefore arises, how the new Swiss Patent Court should deal…

The Swiss Federal Supreme Court rendered its first decision regarding the new pre-trial taking of evidence proceeding in Switzerland’s new Code of Civil Procedure Law (ZPO) and in the Swiss Patent Act (PatG). More than a few patent practitioners feared that the Federal Supreme Court would confirm the challenged decision of the Court of Commerce…

As per January 1, 2012 the Swiss Federal Patent Court became effective. The Federal Patent Court is exclusively competent for: a. validity and infringement disputes and actions for issuing a license in respect of patents; b. ordering preliminary measures prior to the filing of a complaint as defined in letter a; c. the enforcement of…

The gentle reader of this blog knows that on January 1, 2012 the new Federal Patent Court will take up work in Switzerland. As Switzerland’s court of first instance in matters dealing with patents, the Federal Patent Court will rule on civil-law disputes concerning patents. It will rule, for instance, on litigation over patent validity…

The Swiss Federal Supreme Court held in a recent decision that the Swiss company Teva Pharma AG had to bear the court costs and reimburse Novartis’s attorneys’ fees in preliminary injunction proceedings because of Teva’s contradictory conduct in this case. The decision was based on the following facts: On March 16, 2010, Teva was granted…

In a very recently published decision of 4 March 2011 the Swiss Federal Supreme Court dealt with the decision of the Enlarged Board of Appeal 2/08 and approved a dosage regime for a pharmaceutical product as patentable subject matter of a Swiss type claim under the EPC 1973. According to the Supreme Court such claim…

According to the European Court of Justice (ECJ) the envisaged Unified Patent Litigation System (UPLS) is not compatible with the law of the European Union. The main debate is about the influence of the ECJ in patent matters. However, the patent communities in the Member States of the European Union do not seem to be keen on extending the ECJ’s jurisdiction in patent matters and patent practitioners in EPC member states that are not members of the EU are still less.

Two weeks ago the judges of the new Swiss Federal Patent Court convened for the first time for their swearing-in and elected the vice president of the Federal Patent Court among their ranks (Mr. Frank Schnyder). The president (Mr. Dieter Braendle) had been designated by the Federal Swiss Parliament in advance. The Judges will have to determine the new rules of procedure for patent cases pending before the future Federal Patent Court during the next few weeks. Kluwer Patent Blog will keep you posted.